Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reply to “Finding the middle way: rethinking cGMP for sterility testing of cellular therapy products in minimal manipulation settings”

Journal of Clinical Microbiology(2025)10.1128/jcm.01372-25Source: DataRank Database

Reply to “Finding the middle way: rethinking cGMP for sterility testing of cellular therapy products in minimal manipulation settings” is a research paper published in Journal of Clinical Microbiology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (5)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Anna F. Lau ORCID

Live enrichment

PubMed:41231015 PMC:PMC12710322

NIH HHS

National Institutes of Health

NIH HHS

goldLicense: cc-by

publisherhttps://doi.org/10.1128/jcm.01372-25

publisherhttps://journals.asm.org/doi/pdf/10.1128/jcm.01372-25

repositoryhttps://doaj.org/article/c5918e442a1c48c69e2efefe0a896bdb

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12710322/

Europe_PMChttps://europepmc.org/articles/PMC12710322

Keywords

cGMPCell therapySterility TestingCgtpMinimally Manipulated Products